Dr. Hiroshi Yamada, PhDNitto Denko Corporation における Head of Drug Delivery Research and Developmentスピーカー
プロフィール
Hiroshi Yamada, Ph.D., is Head of Drug Delivery Research and Development in the Nucleic Acid Medicine Business Division at Nitto Denko Corporation. He has over 25 years of pharmaceutical industry experience across pharmacology, safety assessment, early development, business development, and corporate strategy. His expertise spans small molecules, antibodies, viral vectors, and lipid nanoparticles (LNPs). He currently leads LNP platform innovation, including cell-targeted delivery and in vivo CAR-T technologies, advancing scalable, partner-ready nucleic acid medicine solutions with strong translational, regulatory, commercial potential for pharmaceutical collaborations and sustained long-term value creation worldwide across multiple therapeutic areas.
アジェンダセッション
Surface Avidity Optimization Drives Potent CAR-T Generation with Targeted LNPs
, 8:35amセッションを見る